Edwards Lifesciences (EW) Return on Capital Employed Growth (1y) (2011 - 2026)
Edwards Lifesciences (EW) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 216.00 |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | -26.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41.00 |
| Mar 31, 2026 | -110.00 |
| Dec 31, 2025 | -115.00 |
| Sep 30, 2025 | -264.00 |
| Jun 30, 2025 | -402.00 |
| Mar 31, 2025 | -347.00 |
| Dec 31, 2024 | -472.00 |
| Sep 30, 2024 | -56.00 |
| Jun 30, 2024 | 9.00 |
| Mar 31, 2024 | -389.00 |
| Dec 31, 2023 | -343.00 |
| Sep 30, 2023 | -671.00 |
| Jun 30, 2023 | -599.00 |
| Mar 31, 2023 | -365.00 |
| Dec 31, 2022 | -303.00 |
| Sep 30, 2022 | -201.00 |
| Jun 30, 2022 | -264.00 |
| Mar 31, 2022 | 888.00 |
| Dec 31, 2021 | 850.00 |
| Sep 30, 2021 | 915.00 |